KPC(SH:600422) Zheng Quan Zhi Xing·2025-06-20 11:11Group 1 - The core opinion of the article is that the legal opinion provided by Beijing DeHeng Law Offices confirms the legality and validity of the 2024 annual shareholders' meeting of Kunming Pharmaceutical Group Co., Ltd. [1][3] Group 2 - The shareholders' meeting was held on June 20, 2025, at the company's management center in Kunming, with a notice period of over 20 days, consistent with the announcement details [2] - A total of 514 shareholders and their proxies attended the meeting, representing 387,491,022 shares, which accounts for 51.1893% of the total voting shares [2] - The meeting was presided over by the company's chairman, Mr. Wu Wendo, in compliance with legal and regulatory requirements [2] Group 3 - The voting process combined on-site and online voting, with six proposals reviewed and approved, including the 2024 annual reports and profit distribution plan [3] - The legal opinion concludes that all aspects of the shareholders' meeting, including convening, attendance qualifications, and voting procedures, complied with legal and regulatory standards [3]